CME Group Inc. (NASDAQ:CME) has been assigned an average recommendation of “Buy” from the ten analysts that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $136.00.

CME has been the topic of several analyst reports. Royal Bank Of Canada set a $130.00 target price on shares of CME Group and gave the stock a “buy” rating in a report on Monday, June 12th. UBS AG reaffirmed a “buy” rating and issued a $134.00 target price (down previously from $136.00) on shares of CME Group in a report on Monday, June 5th. Citigroup Inc. initiated coverage on shares of CME Group in a report on Wednesday, July 12th. They issued a “buy” rating and a $140.00 target price on the stock. Jefferies Group LLC reaffirmed a “buy” rating and issued a $128.00 target price on shares of CME Group in a report on Monday, July 10th. Finally, Deutsche Bank AG lowered their target price on shares of CME Group from $139.00 to $136.00 and set a “buy” rating on the stock in a report on Tuesday, July 4th.

COPYRIGHT VIOLATION NOTICE: “CME Group Inc. (CME) Receives $135.14 Consensus Target Price from Analysts” was originally reported by Daily Political and is the sole property of of Daily Political. If you are reading this report on another site, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this report can be viewed at https://www.dailypolitical.com/2017/09/22/cme-group-inc-cme-receives-135-14-consensus-target-price-from-analysts.html.

In other news, Director Martin J. Gepsman sold 200 shares of the firm’s stock in a transaction dated Wednesday, August 9th. The shares were sold at an average price of $126.14, for a total value of $25,228.00. Following the transaction, the director now owns 43,311 shares of the company’s stock, valued at approximately $5,463,249.54. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Dennis Suskind sold 750 shares of the firm’s stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $129.34, for a total transaction of $97,005.00. Following the completion of the transaction, the director now directly owns 5,059 shares in the company, valued at approximately $654,331.06. The disclosure for this sale can be found here. In the last three months, insiders have sold 48,244 shares of company stock worth $6,021,890. Insiders own 0.57% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Intl Fcstone Inc. bought a new position in shares of CME Group in the 2nd quarter valued at about $1,176,000. Toronto Dominion Bank boosted its stake in shares of CME Group by 23.5% in the 2nd quarter. Toronto Dominion Bank now owns 129,458 shares of the financial services provider’s stock valued at $16,214,000 after purchasing an additional 24,592 shares during the last quarter. Cetera Investment Advisers bought a new position in shares of CME Group in the 2nd quarter valued at about $242,000. Advisory Services Network LLC boosted its stake in shares of CME Group by 8,266.3% in the 2nd quarter. Advisory Services Network LLC now owns 6,944 shares of the financial services provider’s stock valued at $870,000 after purchasing an additional 6,861 shares during the last quarter. Finally, WINTON GROUP Ltd boosted its stake in shares of CME Group by 6.4% in the 2nd quarter. WINTON GROUP Ltd now owns 66,331 shares of the financial services provider’s stock valued at $8,307,000 after purchasing an additional 3,983 shares during the last quarter. 82.64% of the stock is currently owned by institutional investors.

CME Group (NASDAQ:CME) traded up 0.28% on Friday, reaching $134.17. 770,681 shares of the company’s stock were exchanged. The firm has a 50-day moving average of $126.73 and a 200-day moving average of $122.14. CME Group has a 12 month low of $98.95 and a 12 month high of $134.36. The firm has a market capitalization of $45.61 billion, a price-to-earnings ratio of 27.39 and a beta of 0.72.

CME Group (NASDAQ:CME) last posted its earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.20 by $0.03. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The business had revenue of $925.00 million for the quarter, compared to analyst estimates of $931.05 million. During the same quarter in the prior year, the firm earned $1.14 EPS. The firm’s quarterly revenue was up 2.1% compared to the same quarter last year. On average, equities analysts expect that CME Group will post $4.82 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 25th. Shareholders of record on Friday, September 8th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 1.97%. The ex-dividend date of this dividend is Thursday, September 7th. CME Group’s dividend payout ratio is currently 53.99%.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.